FG
ABBV icon

Fairman Group’s AbbVie ABBV Stock Holding History

Fairman Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Buy
986
+925
+1,516% +$199K 0.2% 55
2026
Q1 		$13.3K Hold
61
– – 0.01% 144
2025
Q4 		$13.8K Buy
61
+1
+2% +$228 0.01% 141
2025
Q3 		$13.9K Hold
60
– – 0.01% 150
2025
Q2 		$11.1K Buy
60
+1
+2% +$186 0.01% 155
2025
Q1 		$10.4K Sell
59
-9
-13% -$1.75K 0.01% 146
2024
Q4 		$12K Sell
68
-9
-12% -$1.66K 0.01% 149
2024
Q3 		$15.2K Hold
77
– – 0.01% 150
2024
Q2 		$13.1K Buy
77
+1
+1% +$166 0.01% 156
2024
Q1 		$13.8K Sell
76
-420
-85% -$72.4K 0.01% 143
2023
Q4 		$76.8K Buy
+496
New +$72.3K 0.07% 85

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fairman Group's ABBV Position: Q2 2026 in Review

Fairman Group increased its AbbVie (ABBV) stake by 1,516% in Q2 2026, buying an estimated $199K and bringing the position to 986 shares worth $248K. The position accounts for 0.2% of the portfolio, ranked #55.

Fairman Group first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fairman Group held 986 shares of AbbVie worth $248K as of Q2 2026.
  • Fairman Group bought 925 AbbVie shares in Q2 2026, an estimated $199K.
  • AbbVie made up 0.2% of Fairman Group's portfolio in Q2 2026, its #55 holding.
  • Fairman Group first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.